• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同血清学检测方法检测 COVID-19 时 IgM 和 IgG 抗体阳性率的差异;从医护人员检查中获得的经验。

The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers.

机构信息

Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa district, Fukushima 963-8202, Japan; Department of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Department of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan; Southern Tohoku Research Institute for Neuroscience, 7-115, Yatsuyamada, Koriyama, Fukushima 963-8563, Japan.

出版信息

Int Immunopharmacol. 2021 Mar;92:107360. doi: 10.1016/j.intimp.2020.107360. Epub 2020 Dec 30.

DOI:10.1016/j.intimp.2020.107360
PMID:33508702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836839/
Abstract

OBJECTIVES

The objective of this study was to investigate the differences between the results of two serology assays for detection of COVID-19 among medical staff, who are at higher risks of infection.

METHODS

The immunochromatography (ICG) rapid test kit and the chemiluminescence immunoassay (CLIA) quantitative antibody test were performed. The differences in IgM and IgG antibody prevalence in different serological assays were descriptively analyzed.

RESULTS

A total of 637 participants were included in this research. Two staff were IgM positive in the CLIA quantitative antibody test (cutoff value: 10 AU/ml) of 51 staff who were IgM positive in the rapid test kit. Six staff were IgG positive in the CLIA quantitative antibody test of 56 staff who were IgG positive in the rapid test kit. The proportion of antibody positive staff differed greatly between the rapid test kit and the CLIA quantitative antibody test.

CONCLUSIONS

There was a vast difference in the proportions of IgG and IgM antibody positive staff in the rapid test kit and the CLIA quantitative antibody test results. The results from the only rapid test kit might have to be interpreted with caution. Further studies to evaluate antibody testing accuracy are required to promote the understanding of each assay's characteristics and determine their purposes in each community.

摘要

目的

本研究旨在探讨两种血清学检测方法在感染风险较高的医务人员中检测 COVID-19 的结果差异。

方法

采用免疫层析(ICG)快速检测试剂盒和化学发光免疫分析(CLIA)定量抗体检测试剂盒进行检测。对不同血清学检测方法中 IgM 和 IgG 抗体阳性率的差异进行描述性分析。

结果

本研究共纳入 637 名参与者。在 51 名快速检测试剂盒 IgM 阳性的工作人员中,有 2 名工作人员在 CLIA 定量抗体检测(10 AU/ml 为临界值)中 IgM 阳性。在 56 名快速检测试剂盒 IgG 阳性的工作人员中,有 6 名工作人员在 CLIA 定量抗体检测中 IgG 阳性。两种检测试剂盒的抗体阳性工作人员比例差异很大。

结论

快速检测试剂盒和 CLIA 定量抗体检测结果中 IgG 和 IgM 抗体阳性工作人员的比例存在很大差异。仅使用快速检测试剂盒的结果可能需要谨慎解释。需要进一步研究评估抗体检测的准确性,以促进对每种检测方法特点的理解,并确定其在每个社区中的用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c9e/7836839/e3eea6e42cd3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c9e/7836839/e3eea6e42cd3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c9e/7836839/e3eea6e42cd3/gr1_lrg.jpg

相似文献

1
The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers.不同血清学检测方法检测 COVID-19 时 IgM 和 IgG 抗体阳性率的差异;从医护人员检查中获得的经验。
Int Immunopharmacol. 2021 Mar;92:107360. doi: 10.1016/j.intimp.2020.107360. Epub 2020 Dec 30.
2
Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.五种用于 SARS-CoV-2 抗体诊断的免疫分析方法在真实临床常规检测环境中的临床诊断性能评估。
Pan Afr Med J. 2021 May 3;39:3. doi: 10.11604/pamj.2021.39.3.26471. eCollection 2021.
3
Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.基于自动化荧光免疫分析的快速 SARS-CoV-2 IgM 和 IgG 检测试剂盒的开发、性能评估和临床应用。
J Med Virol. 2021 May;93(5):2838-2847. doi: 10.1002/jmv.26696. Epub 2021 Mar 1.
4
Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.日本福岛县农村地区医院工作人员中 SARS-CoV-2 抗体的血清流行率:一项历史队列研究。
Int Immunopharmacol. 2021 Sep;98:107884. doi: 10.1016/j.intimp.2021.107884. Epub 2021 Jun 14.
5
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.快速免疫层析法与化学发光免疫分析法检测抗 SARS-CoV-2 IgM 和 IgG 的比较。
Biochem Med (Zagreb). 2020 Oct 15;30(3):030901. doi: 10.11613/BM.2020.030901.
6
Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.2019新型冠状病毒病例血清学检测的血清阳性率及诊断准确性:个体研究的汇总分析
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10208-10218. doi: 10.26355/eurrev_202010_23243.
7
Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study.血清学检测 IgG 和 IgM 对 SARS-CoV-2 的准确性:一项前瞻性、横断面研究。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1891-1898. doi: 10.1007/s10096-021-04224-3. Epub 2021 Apr 10.
8
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.2020年新冠疫情期间,在意大利北部一家大型教学医院,将严重急性呼吸综合征冠状病毒2型IgG/IgM快速检测作为住院患者和医护人员的诊断工具。
New Microbiol. 2020 Oct;43(4):161-165. Epub 2020 Oct 31.
9
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时,出现了出乎意料的高频率非特异性反应,这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.
10
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.新型冠状病毒血清学检测方法在 SARS-CoV-2 感染和 COVID-19 诊断中的研究进展。
Front Public Health. 2021 Feb 18;8:620222. doi: 10.3389/fpubh.2020.620222. eCollection 2020.

引用本文的文献

1
Group of longitudinal adverse event patterns after the fourth dose of COVID-19 vaccination with a latent class analysis.第四剂 COVID-19 疫苗接种后纵向不良事件模式的潜伏类分析。
Front Public Health. 2024 Jul 30;12:1406315. doi: 10.3389/fpubh.2024.1406315. eCollection 2024.
2
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection.针对 SARS-CoV-2 蛋白的 IgG 和 IgA 滴度及其与轻症 COVID-19 感染症状的关系。
Sci Rep. 2024 Jun 3;14(1):12725. doi: 10.1038/s41598-024-59634-y.
3
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.

本文引用的文献

1
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey.用于全国 COVID-19 血清流行率调查的 SARS-CoV-2 侧向流动检测的临床和实验室评估。
Thorax. 2020 Dec;75(12):1082-1088. doi: 10.1136/thoraxjnl-2020-215732. Epub 2020 Aug 12.
2
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.基于中性粒细胞与淋巴细胞比值和IgG水平的免疫表型分析可预测COVID-19患者的疾病严重程度和预后。
Front Mol Biosci. 2020 Jul 3;7:157. doi: 10.3389/fmolb.2020.00157. eCollection 2020.
3
五剂 mRNA 疫苗可能抑制原始株刺激的 SARS-CoV2 特异性细胞免疫:来自日本福岛疫苗接种社区调查的队列研究。
Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023.
4
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.新型冠状病毒疾病 2019 年第三次接种后全身不良反应模式与体液和细胞免疫长期动态变化的相关性研究。
Sci Rep. 2023 Jun 7;13(1):9264. doi: 10.1038/s41598-023-36429-1.
5
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.加强接种疫苗后针对新冠病毒的不同细胞免疫反应:来自日本福岛疫苗接种社区调查的队列研究
Vaccines (Basel). 2023 Apr 29;11(5):920. doi: 10.3390/vaccines11050920.
6
High seroprevalence of antibodies against SARS-CoV-2 among healthcare workers 8 months after the first wave in Aden, Yemen.也门亚丁第一波疫情过去8个月后,医护人员中抗新冠病毒抗体的血清阳性率很高。
PLOS Glob Public Health. 2022 Nov 9;2(11):e0000767. doi: 10.1371/journal.pgph.0000767. eCollection 2022.
7
Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study.透析患者加强接种新冠疫苗后针对严重急性呼吸综合征冠状病毒2的抗体和T细胞反应:一项前瞻性观察研究
Vaccines (Basel). 2023 Jan 25;11(2):260. doi: 10.3390/vaccines11020260.
8
Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima.BNT162b2疫苗接种后体液免疫的减弱及其影响因素:在福岛进行的一项采用潜在生长曲线模型的队列研究
Vaccines (Basel). 2022 Nov 25;10(12):2007. doi: 10.3390/vaccines10122007.
9
Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort.血液透析患者与匹配队列对 SARS-CoV-2 疫苗的体液反应。
BMJ Open. 2022 Nov 8;12(11):e065741. doi: 10.1136/bmjopen-2022-065741.
10
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.接种第二剂 BNT162b2 疫苗后在日本社区的体液免疫:福岛疫苗接种社区调查的观察性横断面研究。
Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x.
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice.
迈向严重急性呼吸综合征冠状病毒2血清学检测在临床实践中的合理应用。
Clin Chem Lab Med. 2020 Sep 25;58(10):e189-e191. doi: 10.1515/cclm-2020-0880.
4
Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?诊断性能和阈值:血清学 SARS-CoV-2 检测方法协调的关键?
Clin Chim Acta. 2020 Oct;509:1-7. doi: 10.1016/j.cca.2020.05.050. Epub 2020 May 30.
5
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.在 COVID-19 患者中,七种快速 IgG/IgM 抗体检测试剂盒与 Euroimmun IgA/IgG ELISA 的诊断性能比较。
Clin Microbiol Infect. 2020 Aug;26(8):1082-1087. doi: 10.1016/j.cmi.2020.05.023. Epub 2020 May 28.
6
Testing for Novel Coronavirus Antibodies: A Necessary Adjunct.新型冠状病毒抗体检测:一项必要的辅助手段。
J Infect Dis. 2020 Jul 6;222(3):517-518. doi: 10.1093/infdis/jiaa283.
7
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.评价两种自动化和三种快速侧向流动免疫测定法用于检测抗 SARS-CoV-2 抗体。
J Clin Virol. 2020 Jul;128:104413. doi: 10.1016/j.jcv.2020.104413. Epub 2020 May 5.
8
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19.临床评估免疫层析法 IgM/IgG 抗体检测试剂盒与胸部计算机断层扫描在 COVID-19 诊断中的应用。
J Clin Virol. 2020 Jul;128:104393. doi: 10.1016/j.jcv.2020.104393. Epub 2020 Apr 30.
9
Diagnostic performance of COVID-19 serology assays.新型冠状病毒肺炎血清学检测的诊断性能
Malays J Pathol. 2020 Apr;42(1):13-21.
10
COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil.COVID-19:巴西注册的商业检测试剂盒诊断准确性的荟萃分析。
Braz J Infect Dis. 2020 Mar-Apr;24(2):180-187. doi: 10.1016/j.bjid.2020.04.003. Epub 2020 Apr 18.